Skip to main content
TipRanks
Go Ultimate75% OFF

Bruce Frederick Scharschmidt Insider Profile

4 Followers

Bruce Frederick Scharschmidt, former SVP & CMO at Hyperion Therapeutics, holds 0.00 shares in Hyperion Therapeutics (Ticker: HPTX).

Bruce Frederick Scharschmidt's Trading History

HPTX
Hyperion Therapeutics
May 08, 2015―Uninformative Sell6.76M―
HPTX
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 08, 2015Uninformative Sell$6.76M146,944$46.00―
May 01, 2015Informative Buy$43.93K6,975$6.29―
Mar 03, 2015Informative Sell$890.82K29,800$29.89-54.40%
Feb 10, 2015Uninformative Buy$0.0014,000$0.00―
Jan 05, 2015Uninformative Sell$14.37K592$24.28―

You May Also Like

Bruce Frederick Scharschmidt insider profile FAQ

What is the percentage of profitable transactions made by Bruce Frederick Scharschmidt?
The percentage of profitable transactions made by Bruce Frederick Scharschmidt is 86%.
What is the average return per transaction made by Bruce Frederick Scharschmidt?
The average return per transaction made by Bruce Frederick Scharschmidt is 10.40%.
What stocks does Bruce Frederick Scharschmidt hold?
Bruce Frederick Scharschmidt holds: HPTX stocks.
What was Bruce Frederick Scharschmidt’s latest transaction?
Bruce Frederick Scharschmidt’s latest transaction was an Uninformative Sell of $6.76M.
What was Bruce Frederick Scharschmidt's most profitable transaction?
Bruce Frederick Scharschmidt’s most profitable transaction was an Informative Buy of HPTX stock on December 24, 2014. The return on the trade was 35.90%.
What is Bruce Frederick Scharschmidt's role in Hyperion Therapeutics?
Bruce Frederick Scharschmidt's role in Hyperion Therapeutics is SVP & CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.